Pancreatic exocrine insufficiency after non-pancreatic upper gastrointestinal surgery: meta-analysis
British Journal of Surgery · 03.01.2024 · 111 (1)
DOI: 10.1093/bjs/znad369 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift British Journal of Surgery, online erschienen am 08.12.2023. Verfasst von Lewis A Hall und 6 weiteren Autor:innen. Beteiligte Einrichtung: Liver Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Pancreas, Exocrine Pancreatic Insufficiency. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Arthur Thomson Trust, College of Medical and Dental Sciences, University of Birmingham.
Abstract (Originalsprache)
Background
Untreated pancreatic exocrine insufficiency (PEI) results in substantial patient harm. Upper gastrointestinal surgery (bariatric metabolic surgery and oesophagogastric resection) affects the delicate physiology of pancreatic exocrine function and may result in PEI. The aim of this study was to assimilate the literature on incidence, diagnosis, and management of PEI after bariatric metabolic surgery and oesophagogastric resection.
Methods
A systematic review of PubMed, MEDLINE, and Embase databases identified studies investigating PEI after non-pancreatic upper gastrointestinal surgery. Meta-analyses were undertaken for incidence of PEI and benefit of pancreatic enzyme replacement therapy.
Results
Among 1620 patients from 24 studies included in quantitative synthesis, 36.0% developed PEI. The incidence of PEI was 23.0 and 50.4% after bariatric metabolic surgery and oesophagogastric resection respectively. Notably, the incidence of PEI was 44% after biliopancreatic diversion with duodenal switch and 66.2% after total gastrectomy. The most common diagnostic test used was faecal elastase 1 (15 of 31 studies), with less than 200 µg/g being diagnostic of PEI. A total of 11 studies considered the management of pancreatic exocrine insufficiency, with 78.6% of patients responding positively to pancreatic enzyme replacement when it was prescribed.
Conclusion
PEI is common after non-pancreatic upper gastrointestinal surgery and patients may benefit from enzyme replacement therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Liver Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK.
- College of Medical and Dental Scientists, University of Birmingham, Birmingham, UK.
- Department Therapies and Dietetics, Churchill Hospital, Oxford University Hospitals Foundation NHS Trust, Oxford, UK.
- Department of Bariatric Surgery and Upper Gastrointestinal Surgery, Birmingham Heartlands Hospital, University Hospitals Birmingham, Birmingham, UK.
- Nuffield Department of Surgery, University of Oxford, Oxford, UK.
ORCID-Profile: Sarah Powell-Brett, James Halle-Smith, Tom Wiggins
Förderung
- Arthur Thomson Trust
- College of Medical and Dental Sciences, University of Birmingham
Zitieren
APA
Hall, L. A., Powell-Brett, S., Halle-Smith, J., Ward, L., Wiggins, T., Markar, S. R., & Roberts, K. J. (2024). Pancreatic exocrine insufficiency after non-pancreatic upper gastrointestinal surgery: meta-analysis. British Journal of Surgery, 111(1). https://doi.org/10.1093/bjs/znad369
Vancouver
Hall LA, Powell-Brett S, Halle-Smith J, Ward L, Wiggins T, Markar SR, et al. Pancreatic exocrine insufficiency after non-pancreatic upper gastrointestinal surgery: meta-analysis. British Journal of Surgery. 2024;111(1). doi:10.1093/bjs/znad369
BibTeX
@article{Hall2024,
author = {Hall, Lewis A and Powell-Brett, Sarah and Halle-Smith, James and Ward, Liz and Wiggins, Tom and Markar, Sheraz R and Roberts, Keith J},
title = {Pancreatic exocrine insufficiency after non-pancreatic upper gastrointestinal surgery: meta-analysis},
journal = {British Journal of Surgery},
year = {2024},
volume = {111},
number = {1},
doi = {10.1093/bjs/znad369}
}
EUVIMED